š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This project focuses on development of new strategy for the prevention of e...
Status
Completed
Location
Joslin Diabetes Center
Start Date
2016-01
Trial ID
NCT02660242
Treatments Being Tested
Closed-loop strategy is composed of three components: glucose sensor to rea...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02846857
Closed-loop strategy is composed of three components: glucose sensor to rea...
Status
Completed
Location
Institut de recherches cliniques de MontrƩal
Start Date
2014-06
Trial ID
NCT02189694
Treatments Being Tested
The purpose of this study is to determine if a small dose of glucagon (mini...
Status
Completed
Location
University of Colorado/Barbara Davis Center for Diabetes
Start Date
2015-09
Trial ID
NCT02411578
Treatments Being Tested
Closed-loop strategy is composed of three components: glucose sensor to rea...
Status
Completed
Location
Institut de recherches cliniques de MontrƩal
Start Date
2014-10
Trial ID
NCT02282254
Treatments Being Tested
The purpose of the study is to demonstrate that mini-doses of stable liquid...
Status
Completed
Location
Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital
Start Date
2014-03
Trial ID
NCT02081014
Treatments Being Tested
This proof-of-principle study to assess effects of different doses (mini an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04192019
Treatments Being Tested
This study aimed to develop a new approach for the treatment of fasting ind...
Status
Completed
Location
Qassim University
Start Date
2019-04-15
Trial ID
NCT03970772
Treatments Being Tested
Increased glycemic variability has been proposed as an independent predicto...
Status
Unknown
Location
UZ Brussels
Start Date
2011-07
Trial ID
NCT01402037
Treatments Being Tested
A Phase 3b, open-label, randomized, multicenter, safety and tolerability st...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC
Start Date
2015-12
Trial ID
NCT02638805